Cargando…

Clinical evaluation of the first domestically produced generic isosulfan blue injection in sentinel lymph node biopsy for early breast cancer in China: a multicenter, single-arm, open validation trial (CSBrS-024)

Detalles Bibliográficos
Autores principales:	Qu, Fengjiang, Wu, Di, Liu, Yunjiang, Gao, Wei, Wang, Shu, Wang, Siyuan, Jin, Feng, Chen, Bo, Huang, Jian, Sun, Shanshan, Fan, Zhimin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Clinical Observation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509065/ https://www.ncbi.nlm.nih.gov/pubmed/35970595 http://dx.doi.org/10.1097/CM9.0000000000002309

Ejemplares similares

Isosulfan Blue and Anaphylaxis
por: Sajan, Abin, et al.
Publicado: (2021)

10 % fluorescein sodium vs 1 % isosulfan blue in breast sentinel lymph node biopsy
por: Ren, Lidong, et al.
Publicado: (2016)

Analysis of sentinel lymph node biopsy and non-sentinel lymph node metastasis in invasive ductal and invasive lobular breast cancer: a nationwide cross-sectional study (CSBrS-001)
por: Zhang, Juliang, et al.
Publicado: (2021)

Clinical practice guidelines for the diagnosis and treatment of inflammatory breast cancer: Chinese Society of Breast Surgery (CSBrS) Practice Guidelines 2022
por: Ma, Li, et al.
Publicado: (2023)

Clinical practice guidelines for sentinel lymph node biopsy in patients with early-stage breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021
por: Ye, Jing-Ming, et al.
Publicado: (2021)

Clinical practice guideline for breast fibroadenoma: Chinese Society of Breast Surgery (CSBrS) practice guideline 2021
por: Peng, Yuan, et al.
Publicado: (2021)

Clinical practice guidelines for intraductal papilloma: Chinese Society of breast surgery (CSBrS) practice guidelines 2021
por: Wu, Di, et al.
Publicado: (2021)

The outcome of neoadjuvant chemotherapy and the current trend of surgical treatment in young women with breast cancer: A multicenter real-world study (CSBrS-012)
por: Li, Yijun, et al.
Publicado: (2023)

Clinical practice guidelines for ductal carcinoma in situ: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021
por: Zheng, Ang, et al.
Publicado: (2021)

A retrospective clinical study of patients with pregnancy-associated breast cancer among multiple centers in China (CSBrS-008)
por: Jin, Yu-Chun, et al.
Publicado: (2021)

Clinical practice guidelines for post-mastectomy breast reconstruction: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021
por: Li, Yan-Shuang, et al.
Publicado: (2021)

Clinical practice guidelines for pregnancy-associated breast cancer: Chinese society of breast surgery (CSBrS) practice guidelines 2021
por: Chen, Qing, et al.
Publicado: (2021)

Clinical practice guidelines for ultrasound-guided breast lesions and lymph nodes biopsy: Chinese society of breast surgery (CSBrS) practice guidelines 2021
por: Ma, Jin-Fei, et al.
Publicado: (2021)

A multi-center investigation of breast-conserving surgery based on data from the Chinese Society of Breast Surgery (CSBrS-005)
por: Yu, Li-Xiang, et al.
Publicado: (2020)

Clinical practice guidelines for pre-operative evaluation of breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021
por: Zheng, Chao, et al.
Publicado: (2021)

Clinical practice guideline for diagnosis and treatment of hyperplasia of the mammary glands: Chinese Society of Breast Surgery (CSBrS) practice guideline 2021
por: Ma, Wei, et al.
Publicado: (2021)

Clinical practice guidelines for visualized percutaneous breast tissue clips: Chinese Society of Breast Surgery (CSBrS) practice guideline 2021
por: Chen, Wu-Zhen, et al.
Publicado: (2021)

Clinical practice guidelines for diagnosis and treatment of invasive breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021
por: Liu, Miao, et al.
Publicado: (2021)

Efficacy analysis of neoadjuvant chemotherapy with or without anthracyclines in female patients with HER2-positive breast cancer in China: a nationwide, multicenter, 10-year retrospective study (CSBrS-012)
por: Chen, Heyan, et al.
Publicado: (2023)

Clinical practice guidelines for ultrasound-guided vacuum-assisted breast biopsy: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021
por: Li, Si-Jie, et al.
Publicado: (2021)

Clinical practice guidelines for diagnosis and treatment of patients with non-puerperal mastitis: Chinese Society of Breast Surgery (CSBrS) practice guideline 2021
por: Zhou, Fei, et al.
Publicado: (2021)

Clinical information and management status of de novo stage IV breast cancer patients: a Chinese multicenter investigation (CSBrS-002)
por: Zheng, Ang, et al.
Publicado: (2021)

Clinical characteristics and clinicopathological correlations of bilateral breast cancer in China: A multicenter study from Chinese Society of Breast Surgery (CSBrS-006)
por: Li, Xuelu, et al.
Publicado: (2021)

Clinical practice guidelines for multigene assays in patients with early-stage breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021
por: Zhu, Jiu-Jun, et al.
Publicado: (2021)

Clinical practice guideline of BRCA1/2 testing for patients with breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guideline 2021
por: Xie, Fei, et al.
Publicado: (2021)

Clinical practice guideline for breast-conserving surgery in patients with early-stage breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021
por: Chen, Kai, et al.
Publicado: (2021)

Clinical practice guidelines for endoscopic breast surgery in patients with early-stage breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021
por: Tang, Peng, et al.
Publicado: (2021)

Clinical practice guidelines for risk assessment to identify women at high risk of breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021
por: Wang, Fei, et al.
Publicado: (2021)

Multi-center investigation of breast reconstruction after mastectomy from Chinese Society of Breast Surgery: A survey based on 31 tertiary hospitals (CSBrS-004)
por: Xu, Feng, et al.
Publicado: (2021)

Neoadjuvant therapy for early human epidermal growth factor receptor 2 positive breast cancer in China: A multicenter real-world study (CSBrS-015)
por: Cheng, Yuanjia, et al.
Publicado: (2022)

Survival in Breast Cancer Patients with Bone Metastasis: A Multicenter Real-World Study on the Prognostic Impact of Intensive Postoperative Bone Scan after Initial Diagnosis of Breast Cancer (CSBrS-023)
por: Yang, Liu, et al.
Publicado: (2022)

Melanoma and satellite blue papule
por: Oliveira, André, et al.
Publicado: (2014)

Blue nevus with a starburst pattern on dermoscopy
por: Shiga, Takeo, et al.
Publicado: (2012)

Sentinel Cards Provide Practical SARS-CoV-2 Monitoring in School Settings
por: Cantú, Victor J., et al.
Publicado: (2022)

Breast-conserving surgery and sentinel lymph node biopsy for breast cancer and their correlation with the expression of polyligand proteoglycan-1
por: Li, Fu-Ming, et al.
Publicado: (2022)

The long history of a melanoma associated with a congenital large plaque type blue nevus with subcutaneous cellular nodules
por: Savoia, Francesco, et al.
Publicado: (2015)

A pre-zygotic barrier to hybridization in two con-generic species of scleractinian corals
por: Baird, Andrew H., et al.
Publicado: (2013)

Effectiveness and safety of generic and brand direct acting antivirals for treatment of chronic hepatitis C
por: Abdulla, Maheeba, et al.
Publicado: (2022)

An Account of a Dropsy Cured by Blue Vitriol
Publicado: (1781)

Clinical characteristics of sentinel polyps and their correlation with proximal colon cancer: A retrospective observational study
por: Wang, Man, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qulnjmphbo8t32n1bfqf2tqb6e